Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy
- PMID: 22079723
- DOI: 10.1016/j.ijrobp.2011.06.1987
Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy
Abstract
Purpose: To evaluate prognostic factors for survival after stereotactic radiosurgery (SRS) for new, progressive, or recurrent brain metastases (BM) after prior whole brain radiotherapy (WBRT).
Methods and materials: Patients treated between 1991 and 2007 with Gamma Knife SRS for BM after prior WBRT were retrospectively reviewed. Potential prognostic factors were analyzed overall and by primary site using univariate and stepwise multivariate analyses and recursive partitioning analysis, including age, Karnofsky performance status (KPS), primary tumor control, extracranial metastases, number of BM treated, total SRS target volume, and interval from WBRT to SRS.
Results: A total of 310 patients were analyzed, including 90 breast, 113 non-small-cell lung, 31 small-cell lung, 42 melanoma, and 34 miscellaneous patients. The median age was 56, KPS 80, number of BM treated 3, and interval from WBRT to SRS 8.1 months; 76% had controlled primary tumor and 60% had extracranial metastases. The median survival was 8.4 months overall and 12.0 vs. 7.9 months for single vs. multiple BM treated (p = 0.001). There was no relationship between number of BM and survival after excluding single-BM patients. On multivariate analysis, favorable prognostic factors included age <50, smaller total target volume, and longer interval from WBRT to SRS in breast cancer patients; smaller number of BM, KPS >60, and controlled primary in non-small-cell lung cancer patients; and smaller total target volume in melanoma patients.
Conclusions: Among patients treated with salvage SRS for BM after prior WBRT, prognostic factors appeared to vary by primary site. Although survival time was significantly longer for patients with a single BM, the median survival time of 7.9 months for patients with multiple BM seems sufficiently long for salvage SRS to appear to be worthwhile, and no evidence was found to support the use of a cutoff for number of BM appropriate for salvage SRS.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.J Neurosurg. 2014 Dec;121 Suppl:75-83. doi: 10.3171/2014.6.GKS14708. J Neurosurg. 2014. PMID: 25434940
-
Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases.Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):385-9. doi: 10.1016/j.ijrobp.2009.08.027. Epub 2010 Jan 25. Int J Radiat Oncol Biol Phys. 2010. PMID: 20097485
-
Gamma Knife radiosurgery for brain metastases from primary breast cancer.Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1132-40. doi: 10.1016/j.ijrobp.2008.12.031. Epub 2009 Apr 3. Int J Radiat Oncol Biol Phys. 2009. PMID: 19345514
-
γ knife radiosurgery of brain metastasis from breast cancer.Prog Neurol Surg. 2012;25:156-62. doi: 10.1159/000331189. Epub 2012 Jan 6. Prog Neurol Surg. 2012. PMID: 22236677 Review.
-
Radiation therapy for brain metastases in breast cancer patients.Breast Cancer. 2011 Oct;18(4):244-51. doi: 10.1007/s12282-010-0207-8. Epub 2010 May 11. Breast Cancer. 2011. PMID: 20458564 Review.
Cited by
-
Prognostic factors of brain metastases from colorectal cancer.BMC Cancer. 2019 Jul 31;19(1):755. doi: 10.1186/s12885-019-5973-x. BMC Cancer. 2019. PMID: 31366387 Free PMC article.
-
Laser interstitial thermal therapy as an adjunct therapy in brain tumors: A meta-analysis and comparison with stereotactic radiotherapy.Surg Neurol Int. 2020 Oct 29;11:360. doi: 10.25259/SNI_152_2020. eCollection 2020. Surg Neurol Int. 2020. PMID: 33194293 Free PMC article. Review.
-
Controversies in the Therapy of Brain Metastases: Shifting Paradigms in an Era of Effective Systemic Therapy and Longer-Term Survivorship.Curr Treat Options Oncol. 2016 Sep;17(9):46. doi: 10.1007/s11864-016-0423-3. Curr Treat Options Oncol. 2016. PMID: 27447703 Review.
-
The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases.J Neurooncol. 2013 Jul;113(3):459-65. doi: 10.1007/s11060-013-1138-y. Epub 2013 May 10. J Neurooncol. 2013. PMID: 23661101 Clinical Trial.
-
Adaptive hypofractionated gamma knife radiosurgery in the acute management of brainstem metastases.Surg Neurol Int. 2019 Jan 29;10:14. doi: 10.4103/sni.sni_53_18. eCollection 2019. Surg Neurol Int. 2019. PMID: 30783544 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical